Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose vs conventional-dose meropenem in sepsis: lactate clearance (post-hoc RCT analysis)
TCTR20200311001Phase 3Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of meropenem in sepsis, sponsored by Ramathibodi Hospital. Started Dec 2017; status: completed.
02
Drugs
meropenem
03
Conditions
sepsis
Beyond the preview
Go deeper on TCTR20200311001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200311001.